GlaxoSmithKline Dividend: GlaxoSmithKline Pharmaceuticals has announced a bumper dividend for its shareholders along with the Q4FY26 results. In an exchange filing, GlaxoSmithKline Pharmaceuticals said that its board has recommended a whopping dividend of 570 per cent or Rs 57 per share of Rs 10 face value.

The dividend of Rs 57 is, however, subject to the approval by the shareholders of the company at the Annual General Meeting (AGM).

"The Board has recommended a final dividend of Rs 57 per equity share on the face value of Rs 10 each for the year ended 31st March 2026, subject to approval of members at the 101st Annual General Meeting," the filing said.

GlaxoSmithKline Dividend Record Date

GlaxoSmithKline Pharmaceuticals in the same filing said that the board has fixed Tuesday, 30th June 2026, as the date of the 101st AGM

According to the filing, the board has fixed Friday, 29th May 2026, as the Record Date for determining entitlement of members to the final dividend for the financial year ended 31st March, 2026.

GlaxoSmithKline Dividend Payment Date

If the Rs 57 dividend is approved at the AGM by the shareholders, the same will be paid to the eligible shareholders on or after July 1, 2026.

"If the final dividend as recommended by the Board of Directors is approved at the AGM, payment of such dividend, subject to deduction of tax at source, will be made on and after Wednesday, 1st July 2026," GlaxoSmithKline Pharmaceuticals said in a filing.

GlaxoSmithKline Pharmaceuticals Q4 Results

GlaxoSmithKline Pharmaceuticals Q4 consolidated PAT: Rs 277.86 crore, up 5.7 per cent YoY

GlaxoSmithKline Pharmaceuticals Q4 revenue from operations: Rs 995.3 crore

GlaxoSmithKline Pharmaceuticals Q4 total expenses: Rs 658.15 crore

GlaxoSmithKline Pharmaceuticals FY26 consolidated profit: Rs 1,035.98 crore

GlaxoSmithKline Pharmaceuticals FY26 consolidated revenue from operations: Rs 3,821.67 crore 

Vodafone Idea: Dhurandhar stock by Rakesh Bansal; check target